Current Opinion in Urology

Papers
(The H4-Index of Current Opinion in Urology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial introductions75
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies52
Research frontiers in urology51
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects47
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker28
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis27
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma23
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update23
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments20
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology20
The role of innovations in advancing urologic oncologic patient care20
Tissue-based gene expression testing in localized prostate cancer19
Editorial introductions17
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder17
Editorial introductions16
Editorial introductions15
RNA-based urinary assays for non-muscle invasive bladder cancer15
Testicular cancer with small metastatic burden: optimal approach in 202415
0.23963904380798